Table 1 Summary of trial characteristics
Characteristic | Trials (k = 186) |
|---|---|
Number of patients | 16,655 |
Proportion of women (SD) | 58.6 (28.6) |
Mean age, years (SD) | 39.9 (17.1) |
Condition | |
Abortion, n (%) | 3 (1.6) |
Anxiety, n (%) | 3 (1.6) |
Asthma, n (%) | 3 (1.6) |
Cancer, n (%) | 5 (2.9) |
Dementia, n (%) | 3 (1.6) |
Depression, n (%) | 9 (4.8) |
Fibromyalgia, n (%) | 3 (1.6) |
Headache, n (%) | 8 (4.3) |
Hypertension, n (%) | 7 (3.8) |
Insomnia, n (%) | 5 (2.9) |
Low back pain, n (%) | 3 (1.6) |
Obesity, n (%) | 8 (4.3) |
Osteoarthritis, n (%) | 5 (2.9) |
Phobia, n (%) | 3 (1.6) |
Schizophrenia, n (%) | 3 (1.6) |
Smoking, n (%) | 9 (4.8) |
Surgery/procedure, n (%) | 45 (24.2) |
Othera, n (%) | 61 (32.8) |
No. center | |
Single, n (%) | 97 (52.1) |
Unclear, n (%) | 56 (30.1) |
Multi, n (%) | 33 (17.7) |
Type of intervention | |
Psychological, n (%) | 62 (33.3) |
Pharmacological, n (%) | 56 (30.1) |
Physical, n (%) | 68 (36.6) |
Study duration | |
< 4 weeks, n (%) | 83 (44.6) |
4 to 8 weeks, n (%) | 44 (23.7) |
8 to 12 weeks, n (%) | 27 (14.5) |
> 12 weeks, n (%) | 32 (17.2) |
Outcome domain | |
Anxiety, n (%) | 9 (4.8) |
Depression, n (%) | 10 (5.4) |
Diastolic blood pressure, n (%) | 7 (3.8) |
Medication use, n (%) | 9 (4.8) |
Nausea, n (%) | 9 (4.8) |
Pain, n (%) | 53 (28.5) |
Sleep disturbance, n (%) | 6 (3.2) |
Smoking cessation, n (%) | 9 (4.8) |
Weight, n (%) | 8 (4.3) |
Otherb, n (%) | 66 (35.5) |
High risk, n (%) | 170 (91.4) |